Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma

Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice

(2017) Masaaki Sekine et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Development of Engineered T Cells Expressing a Chimeric CD16-CD3  Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia

(2016) H. Tanaka et al.   CLINICAL CANCER RESEARCH

Recurrence of Psoriasis Vulgaris Accompanied by Treatment with C-C Chemokine Receptor Type 4 (CCR4) Antibody (Mogamulizumab) Therapies in a Patient with Adult T cell Leukemia/ Lymphoma: Insight into Autoinflammatory Diseases

(2016) Kazuho Morichika et al.   INTERNAL MEDICINE

Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia

(2016) H. Ureshino et al.   Cancer Immunology Research

Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma

(2015) M. Duvic et al.   BLOOD

Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study

(2015) Takashi Ishida et al.   BRITISH JOURNAL OF HAEMATOLOGY

Colitis mimicking graft-versus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab

(2015) Kenji Ishitsuka et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Reduction of Regulatory T Cells by Mogamulizumab, a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients with Aggressive/Refractory Mycosis Fungoides and Sezary Syndrome

(2014) X. Ni et al.   CLINICAL CANCER RESEARCH

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

(2014) Michinori Ogura et al.   JOURNAL OF CLINICAL ONCOLOGY

Mogamulizumab

(2012) Joshuan M. Subramaniam et al.   DRUGS

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

(2012) Takashi Ishida et al.   JOURNAL OF CLINICAL ONCOLOGY

Adult T-Cell Leukemia: A Review of Epidemiological Evidence

(2012) Masako Iwanaga et al.   Frontiers in Microbiology

Long-term study of indolent adult T-cell leukemia-lymphoma

(2010) Y. Takasaki et al.   BLOOD

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

(2010) M. Iwanaga et al.   BLOOD

Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes

(2010) Ali Bazarbachi et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma

(2010) Kazuhito Yamamoto et al.   JOURNAL OF CLINICAL ONCOLOGY